Amgen, Inc. (NASDAQ:AMGN)

Short Sellers Run For Cover From Major Biotechs

The short interest data are out for the most recent settlement date, November 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Major Biotechs See Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Stocks were mixed in the premarket on Tuesday and the day was just looking for direction after last week's all-time highs. Investors still have a lot of pressing issues and ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amgen, Beyond Meat, Cisco, Home Depot, Microsoft, RingCentral, Shake Shack, Tilray, Uber, Under Armour, US Steel and More

Stocks were indicated to open higher again on Tuesday morning in a continued breakout to the upside. This is just a day after the Dow Jones industrials and S&P 500 ...
Read Full Story »

Why Amgen Failed to Impress in Q3

When Amgen Inc. (NASDAQ: AMGN) released its third-quarter financial results after the markets closed on Tuesday, the firm said that it had $3.66 in earnings per share (EPS) and $5.7 ...
Read Full Story »

Can Amgen Earnings Keep Up With Biogen?

Amgen Inc. (NASDAQ: AMGN) is set to report its most recent quarterly results after the closing bell on Tuesday. The consensus forecast calls for $3.53 in earnings per share (EPS) ...
Read Full Story »

Alphabet, AT&T, Facebook, Mastercard, Starbucks and More Major Earnings This Week

Now that the third-quarter earnings reporting season is has kicked off, many more major companies will be sharing their results in the coming weeks. Here, 24/7 Wall St. has put ...
Read Full Story »

Major Biotechs See Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, October 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

How Biotech and Big Pharma Have Upside Heading Into Earnings

Biotech and many of the so-called Big Pharma have been duds in 2019. Despite many FDA approvals and some powerful mergers and royalty deals, the political pressure around drug pricing ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Agilent, Alphabet, Altria, Amazon, Boeing, Caterpillar, Chipotle, E*Trade, Gap, Snap, Twitter and More

Stocks were indicated to open marginally higher on Friday as earnings season is so far proving to be not as bad as many investors had modeled in for the third ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Stocks were indicated to open marginally higher on Thursday as the world appears to have better hopes for a Brexit framework out of Europe. Investors are having to grapple with ...
Read Full Story »

Short Sellers Hike Bets in Major Biotechs

The short interest data are out for the most recent settlement date, September 30. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Major Biotechs Scare Off Short Sellers

The short interest data are out for the most recent settlement date, September 13. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alcoa, Amgen, Apache, Chewy, Clorox, Concho Resources, Disney, Edwards Lifesciences, Occidental and More

The futures traded somewhat lower Monday morning after comments over the trade dispute Friday by the U.S. president sent the market lower. With the third quarter almost in the books, ...
Read Full Story »

Major Biotechs Scare Off Short Sellers

The short interest data are out for the most recent settlement date, August 30. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »